雌激素受体α绑定剂用于激素依赖的乳腺癌形式:e-QSAR和分子对接由X射线解析结构支持
Vijay H Masand1, Sami A Al-Hussain2, Abdullah Y Alzahrani3
1Department of Chemistry, Vidya Bharati Mahavidyalaya, Amravati 444 602, Maharashtra, India.
ACS omega
|April 15, 2024
概括
这项研究确定了关键的分子特征,包括特定的原子和结合模式,这些特征对于抑制雌激素受体α (ER-α)至关重要. 这些发现有助于开发针对ER-α的新乳腺癌疗法.
科学领域:
- 药用化学 医学化学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 乳腺癌是一个重大的全球健康挑战,荷尔蒙依赖的亚型通常是由雌激素受体α (ER-α) 驱动的.
- 准ER-α是开发有效乳腺癌治疗方法的关键策略.
- 了解控制ER-α抑制的分子相互作用对于药物设计至关重要.
研究的目的:
- 为ER-α抑制剂开发一个预测性的e-QSAR模型.
- 确定影响ER-α结合的关键分子描述剂.
- 支持新型ER-α向药物的合理设计.
主要方法:
- 使用遗传算法和多线性回归的定量结构-活动关系 (QSAR) 建模.
- 分子对接模拟以预测结合模式.
- 分子动力学 (MD) 模拟以评估结合稳定性.
- 为了验证,对X射线晶体结构进行分析.
主要成果:
- 开发了一个强大的e-QSAR模型,平衡预测能力和机械解释性,遵守经合组织的指导方针.
- 该模型确定了sp2混合的碳和原子对于ER-α结合至关重要.
- 发现键捐赠者/接受者和碳,和环硫等原子的特定组合对结合亲缘关系很重要.
结论:
- 开发的e-QSAR模型为ER-α抑制的结构要求提供了宝贵的见解.
- 分子对接和动力学模拟证实了e-QSAR的发现.
- 这些结果为未来设计和开发用于乳腺癌治疗的新型ER-α抑制剂提供了基础.
更多相关视频
相关概念视频
Structure-Activity Relationships and Drug Design
710
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K
Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K
Quantitative Aspects of Drug-Receptor Interaction
977
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
977


